World Journal of Gastroenterology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Fernandez CJ, Agarwal M, Pottakkat B, Haroon NN, George AS, Pappachan JM. Gastroenteropancreatic neuroendocrine neoplasms: A clinical snapshot. World J Gastrointest Surg 2021; 13(3): 231-255 [PMID: 33796213 DOI: 10.4240/wjgs.v13.i3.231]
URL:	https://www.wjgnet.com/1007-9327/full/v13/i3/231.htm

(326) (318) (0) (0) (0) (20) (11375) (42)

Number	Citing Articles
1	Andrew Canakis, Linda S Lee. Current updates and future directions in diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms. World Journal of Gastrointestinal Endoscopy 2022; 14(5): 267-290 doi: 10.4253/wjge.v14.i5.267 Abstract(1050) \| Core Tip(979) \| Full Article(HTML)(5723) \| Full Article (PDF)-5078K(802) \| Full Article (Word)-3050K(143) \| Audio-1395K(20) \| Peer-Review Report-433K(229) \| Answering Reviewers-160K(249) \| Times Cited (20) \| Total Visits (7975) \| Open
2	D. A. Salimgereeva, I. Y. Feidorov, I. E. Khatkov. Pancreatic resections or observation in management of sporadic non-functioning stage T1 neuroendocrine tumors of the pancreas (PNET) (literature review). Endocrine Surgery 2023; 17(1) doi: 10.14341/serg12775
3	Huiyu Yang, Lin Zhao, Xiang Jing, Yanmin Kan. The Value of Ultrasound and Contrast‐Enhanced Ultrasound in a Young Asymptomatic Patient With Duodenal Neuroendocrine Neoplasms: A Case Report. Journal of Clinical Ultrasound 2025; 53(5) doi: 10.1002/jcu.23957
4	欣王. Advances in CT Radiomics Research on Gastroenteropancreatic Neuroendocrine Neoplasms. Advances in Clinical Medicine 2026; 16(03) doi: 10.12677/acm.2026.1631001
5	Juni Banerjee, Ramya P. Ranjan, Md. Tanjim Alam, Sanika Deshmukh, Prem Prakash Tripathi, Sonu Gandhi, Shuvomoy Banerjee. Virus-associated neuroendocrine cancers: Pathogenesis and current therapeutics. Pathology - Research and Practice 2023; 248 doi: 10.1016/j.prp.2023.154720
6	Kamran Shateri, Fatemeh Halimi shabestari, Mohammad Reza Pashaei. Gallstone Frequency in Adults With Celiac Disease: Results of a Population-Based Celiac Disease Registry From West Azerbaijan, IRAN. Disease and Diagnosis 2022; 11(1) doi: 10.34172/ddj.2022.04
7	Matteo Regolo, Nicolas Cardaci, Clara Salmeri, Alfredo Laudani, Michele Colaci, Massimo Ippolito, Fabio Motta, Salvatore Magrì, Stefanie Parisi, Alfredo Gaetano Torcitto, Lorenzo Malatino. Pancreatic Neuroendocrine Tumor (Pan-NET) Presented by Abdominal Pain: A Case Report and Literature Review. Journal of Clinical Medicine 2023; 12(20) doi: 10.3390/jcm12206617
8	Cecilie Slott, Seppo W. Langer, Stine Møller, Jesper Krogh, Marianne Klose, Carsten Palnæs Hansen, Andreas Kjaer, Pernille Holmager, Rajendra Singh Garbyal, Ulrich Knigge, Mikkel Andreassen. Outlook for 615 Small Intestinal Neuroendocrine Tumor Patients: Recurrence Risk after Surgery and Disease-Specific Survival in Advanced Disease. Cancers 2024; 16(1) doi: 10.3390/cancers16010204
9	Ruoxi Dong, Jingen Lu, Hao Zhou, Qingjun Dong, Chen Wang. Rectal neuroendocrine tumor during anorectal surgery: three case reports and a review of the literature. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1468266
10	Marcio J Concepción-Zavaleta, Jenyfer M Fuentes-Mendoza, José Paz-Ibarra, Luis A Concepción-Urteaga, Jeny Justina Mendoza-Godoy, Jhean G Gonzáles-Yovera, Juan Eduardo Quiroz-Aldave, Frederick Massucco-Revoredo, Augusto Aldave-Herrera, Regina Aquino-Salverredy. Gastroenteropancreatic neuroendocrine tumors in 2025: From molecular profiling to artificial intelligence-driven therapy. World Journal of Gastrointestinal Oncology 2026; 18(3): 114205 doi: 10.4251/wjgo.v18.i3.114205 Abstract(91) \| Core Tip(106) \| Full Article(HTML)(851) \| Full Article (PDF)-1982K(257) \| Full Article with Cover (PDF)-2318K(41) \| Full Article (XML)-300K(54) \| Audio-241K(6) \| Peer-Review Report-221K(44) \| Answering Reviewers-155K(73) \| Times Cited (0) \| Total Visits (1412) \| Open
11	Niko Hiltunen, Niko Kemi, Juha P. Väyrynen, Jan Böhm, Joonas H. Kauppila, Heikki Huhta, Olli Helminen, Luwen Zhang. Toll-like receptors 1–9 in small bowel neuroendocrine tumors–Clinical significance and prognosis. PLOS ONE 2024; 19(5) doi: 10.1371/journal.pone.0302813
12	Naveena Rikhraj, Cornelius J Fernandez, Vanishri Ganakumar, Joseph M Pappachan. Pancreatic neuroendocrine tumors: A case-based evidence review. World Journal of Gastrointestinal Pathophysiology 2025; 16(2): 107265 doi: 10.4291/wjgp.v16.i2.107265 Abstract(380) \| Core Tip(371) \| Full Article(HTML)(2140) \| Full Article (PDF)-3274K(248) \| Full Article with Cover (PDF)-3464K(143) \| Full Article (XML)-112K(109) \| Audio-1821K(38) \| Peer-Review Report-324K(114) \| Answering Reviewers-221K(117) \| Times Cited (6) \| Total Visits (3277) \| Open
13	Durlav Chowdhury, Arunava Mishra, Maikala Muskan Rao, Rohan Sahu, Surendra H. Bodakhe. Immunotherapeutic strategies in gastroenteropancreatic neuroendocrine neoplasms: present condition and future developments. Journal of Chemotherapy 2026; doi: 10.1080/1120009X.2026.2676345
14	Aman Chauhan, Thorvardur R. Halfdanarson, Namrata Vijayvergia. Sequencing Choices and Real-World Clinical Management in Advanced Grade 2/3 GEP-NET Treatment: The Emerging Role of PRRT. Cancers 2025; 17(18) doi: 10.3390/cancers17183008
15	Mehran Erfani, Shokooh Karbasizade. . 2026; 1 doi: 10.66224/infopub.2026.05.06
16	Sanjana Ballal, Madhav P. Yadav, Madhavi Tripathi, Ranjit Kumar Sahoo, Chandrasekhar Bal. Survival Outcomes in Metastatic Gastroenteropancreatic Neuroendocrine Tumor Patients Receiving Concomitant225Ac-DOTATATE–Targeted α-Therapy and Capecitabine: A Real-World-Scenario Management-Based Long-Term Outcome Study. Journal of Nuclear Medicine 2023; 64(2) doi: 10.2967/jnumed.122.264043
17	Ryuichi Yamasaki. Unveiling the GHRHoma syndrome: clinical insights from 100 patients with GHRHomas. Academia Oncology 2025; 2(2) doi: 10.20935/AcadOnco7736
18	Ludovica Magi, Matteo Marasco, Maria Rinzivillo, Antongiulio Faggiano, Francesco Panzuto. Management of Functional Pancreatic Neuroendocrine Neoplasms. Current Treatment Options in Oncology 2023; 24(7) doi: 10.1007/s11864-023-01085-0
19	Emma N. Rizen, Alexandria T. Phan. Neuroendocrine Tumors: a Relevant Clinical Update. Current Oncology Reports 2022; 24(6) doi: 10.1007/s11912-022-01217-z
20	Francesca Corti, Roberta Elisa Rossi, Pietro Cafaro, Gaia Passarella, Antonella Turla, Sara Pusceddu, Jorgelina Coppa, Simone Oldani, Alessandro Guidi, Raffaella Longarini, Diego Luigi Cortinovis. Emerging Treatment Options for Neuroendocrine Neoplasms of Unknown Primary Origin: Current Evidence and Future Perspectives. Cancers 2024; 16(11) doi: 10.3390/cancers16112025
21	Christopher Sakellis, Heather A. Jacene. Neuroendocrine Tumors. PET Clinics 2024; 19(3) doi: 10.1016/j.cpet.2024.03.008
22	Wei Wang, Bo Zhang, Yue Zhang, Pinyi Ma, Xinghua Wang, Ying Sun, Daqian Song, Qiang Fei. Colorimetry and SERS dual-mode sensing of serotonin based on functionalized gold nanoparticles. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2021; 261 doi: 10.1016/j.saa.2021.120057
23	Catherine H. Davis, Amanda M. Laird, Steven K. Libutti. Resistant gastroenteropancreatic neuroendocrine tumors: a definition and guideline to medical and surgical management. Baylor University Medical Center Proceedings 2024; 37(1) doi: 10.1080/08998280.2023.2284039
24	Syedda Ayesha, Masood Muhammad Karim, Abdul Hadi Shahid, Adeel Ur Rehman, Zeeshan Uddin, Shahab Abid. Diagnostic role of endoscopic ultrasonography in defining the clinical features and histopathological spectrum of gastroenteropancreatic neuroendocrine tumors. World Journal of Gastrointestinal Endoscopy 2025; 17(6): 104539 doi: 10.4253/wjge.v17.i6.104539 Abstract(350) \| Core Tip(351) \| Full Article(HTML)(1309) \| Full Article (PDF)-18843K(167) \| Full Article with Cover (PDF)-19069K(173) \| Full Article (XML)-93K(86) \| Audio-984K(66) \| Peer-Review Report-269K(97) \| Answering Reviewers-191K(114) \| Times Cited (4) \| Total Visits (2344) \| Open
25	Efstathios Theodoros Pavlidis, Theodoros Efstathios Pavlidis. Molecular factors, diagnosis and management of gastrointestinal tract neuroendocrine tumors: An update. World Journal of Clinical Cases 2022; 10(27): 9573-9587 doi: 10.12998/wjcc.v10.i27.9573 Abstract(1246) \| Core Tip(1003) \| Full Article(HTML)(3685) \| Full Article (PDF)-769K(477) \| Full Article (Word)-201K(115) \| Audio-381K(13) \| Peer-Review Report-516K(209) \| Answering Reviewers-444K(217) \| Times Cited (6) \| Total Visits (4277) \| Open
26	Luisana Molina-Pimienta, Andrés A. Cuéllar Cuéllar, Mireya Tapiero-García, Alfredo Romero-Rojas, Jesús O. Sanchez-Castillo. Prognostic factors and survival in gastroenteropancreatic neuroendocrine neoplasm: Real-world evidence from a South American Single-Center Cohort. Annales d'Endocrinologie 2025; 86(5) doi: 10.1016/j.ando.2025.102463
27	Niko Hiltunen, Jukka Rintala, Juha P. Väyrynen, Jan Böhm, Tuomo J. Karttunen, Heikki Huhta, Olli Helminen. Monocarboxylate Transporters 1 and 4 and Prognosis in Small Bowel Neuroendocrine Tumors. Cancers 2022; 14(10) doi: 10.3390/cancers14102552
28	Giuseppe Iabichino, Milena Di Leo, Monica Arena, Giovanni Giuseppe Rubis Passoni, Elisabetta Morandi, Francesca Turpini, Paolo Viaggi, Carmelo Luigiano, Luca De Luca. Diagnosis, treatment, and current concepts in the endoscopic management of gastroenteropancreatic neuroendocrine neoplasms. World Journal of Gastroenterology 2022; 28(34): 4943-4958 doi: 10.3748/wjg.v28.i34.4943 Abstract(1326) \| Core Tip(1172) \| Full Article(HTML)(4060) \| Full Article (PDF)-4127K(573) \| Full Article (Word)-786K(106) \| Audio-349K(15) \| Peer-Review Report-958K(233) \| Answering Reviewers-349K(251) \| Times Cited (8) \| Total Visits (6235) \| Open
29	Heying Duan, Andrei Iagaru. Neuroendocrine Tumor Diagnosis. PET Clinics 2023; 18(2) doi: 10.1016/j.cpet.2022.11.008
30	Daniel Hubbs, Thomas Fahey. Endocrine Surgery Clerkship. Contemporary Surgical Clerkships 2024; doi: 10.1007/978-3-031-62091-1_25
31	Niko Hiltunen, Juha P. Väyrynen, Jan Böhm, Olli Helminen. CD3+, CD8+, CD4+ and FOXP3+ T Cells in the Immune Microenvironment of Small Bowel Neuroendocrine Tumors. Diseases 2021; 9(2) doi: 10.3390/diseases9020042
32	Muhammer Ergenç, Hilmi Yazıcı, Furkan Yılmaz, Ahmet Akmercan, Alisina Bulut, Şakir Karpuz, Mümin Coşkun, Emine Bozkurtlar, T. Kıvılcım Uprak, Ali Emre Atıcı, M. Ümit Uğurlu, Asım Cingi, Ömer Günal, Cumhur Yeğen. Clinicopathological Features and Prognostic Factors of Gastroenteropancreatic Neuroendocrine Tumors: A Single-Center Experience. Cancer Control 2026; 33 doi: 10.1177/10732748261445229
33	Federica De Muzio, Fabio Pellegrino, Roberta Fusco, Salvatore Tafuto, Mariano Scaglione, Alessandro Ottaiano, Antonella Petrillo, Francesco Izzo, Vincenza Granata. Prognostic Assessment of Gastropancreatic Neuroendocrine Neoplasm: Prospects and limits of Radiomics. Diagnostics 2023; 13(18) doi: 10.3390/diagnostics13182877
34	Catarina Almeida, Lorenzo Gervaso, Gianmaria Frigè, Francesca Spada, Lavinia Benini, Chiara Alessandra Cella, Luca Mazzarella, Nicola Fazio. The Role of Liquid Biopsy in Gastroenteropancreatic Neuroendocrine Neoplasms. Cancers 2024; 16(19) doi: 10.3390/cancers16193349
35	Michelle Kang Kim, Julie Yang, Natalie Farha, Inessa A. Goldman. Pediatric Gastrointestinal and Liver Disease. 2026; doi: 10.1016/B978-0-443-11760-2.00085-9
36	Ryan Reinardi Wijaya, Hendra Budiawan, Basuki Hidayat, Budi Darmawan, Trias Nugrahadi, Achmad Hussein Sundawa Kartamihardja. Comparison of radiolabeled somatostatin analogs (DOTATATE, DOTANOC, and DOTATOC) in somatostatin receptor (SSTR) imaging for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a narrative literature review. Annals of Nuclear Medicine 2025; 39(8) doi: 10.1007/s12149-025-02072-1
37	Bilal Hameed, Muzzammil Ahmadzada, Timothy S. McNeel, Daniel B. DiCapua, Shahinaz M. Gadalla. A novel discovery of elevated risk of neuroendocrine tumors in patients with myotonic dystrophy. Journal of the Neurological Sciences 2025; 478 doi: 10.1016/j.jns.2025.123722
38	Efstathios T Pavlidis, Ioannis N Galanis, Theodoros E Pavlidis. Critical considerations for the management of gastrointestinal mixed neuroendocrine non-neuroendocrine neoplasms and pure neuroendocrine carcinomas. World Journal of Gastrointestinal Oncology 2024; 16(12): 4559-4564 doi: 10.4251/wjgo.v16.i12.4559 Abstract(623) \| Core Tip(561) \| Full Article(HTML)(1464) \| Full Article (PDF)-416K(188) \| Full Article with Cover (PDF)-730K(179) \| Full Article (XML)-113K(127) \| Audio-1457K(26) \| Peer-Review Report-237K(137) \| Answering Reviewers-131K(140) \| Times Cited (1) \| Total Visits (1958) \| Open
39	Ariadni Spyroglou, Odysseas Violetis, Konstantinos Iliakopoulos, Antonios Vezakis, Krystallenia Alexandraki. Mesenteric Fibrosis in Neuroendocrine Neoplasms: a Systematic Review of New Thoughts on Causation and Potential Treatments. Current Oncology Reports 2025; 27(5) doi: 10.1007/s11912-025-01668-0
40	Vijay W. Dhakre, Sneha Tukaram Galande, Varsha Gunvant Patil, Nikita C. Shah, Chetan Rathod, Kaiumarz S. Sethna, Anjali D. Amrapurkar. Mixed Neuroendocrine and Non-Neuroendocrine Neoplasm of Pancreas: What Do We Know, What Have We Learnt?. Gastrointestinal Tumors 2023; 10(1) doi: 10.1159/000528759
41	Vincent Hautefeuille, Thomas Walter, Christine Do Cao, Romain Coriat, Sophie Dominguez, Laurent Mineur, Guillaume Cadiot, Eric Terrebonne, Iradj Sobhani, Delphine Gueguen, Aude Houchard, Charbel Mouawad, Amélie Anota, Pascal Hammel. OPERA: perception of information in patients with gastroenteropancreatic neuroendocrine tumors on lanreotide autogel. European Journal of Endocrinology 2023; 189(2) doi: 10.1093/ejendo/lvad094
42	Jassimran Singh, Hallbera Gudmundsdottir, Thorvardur R. Halfdanarson, Sean P. Cleary, Michael L. Kendrick, Mark J. Truty, Rory L. Smoot, David M. Nagorney, Santhi Swaroop Vege. Pancreatic Neuroendocrine Tumors—A Descriptive Study of the Presenting Features in a 20-Year Surgical Resection Cohort at a Tertiary Institution. Pancreas 2025; 54(5) doi: 10.1097/MPA.0000000000002452